128366-07-4 Usage
Uses
Used in Pharmaceutical Industry:
(3E)-3-[(cyclohexylamino)(hydroxy)methylidene]quinoline-2,4(1H,3H)-dione is used as a potential therapeutic agent for its anti-inflammatory and anticancer properties. It has shown promise in the treatment of various types of cancer and could be developed into a pharmaceutical product to combat these diseases.
Used in Research and Development:
In the field of medical research, (3E)-3-[(cyclohexylamino)(hydroxy)methylidene]quinoline-2,4(1H,3H)-dione is used as a subject of study for its potential applications in treating neurodegenerative diseases. Its properties and mechanisms of action are being investigated to better understand how it could be utilized in the development of new treatments for such conditions.
Used in Drug Delivery Systems:
Similar to gallotannin, (3E)-3-[(cyclohexylamino)(hydroxy)methylidene]quinoline-2,4(1H,3H)-dione could potentially be incorporated into novel drug delivery systems to enhance its bioavailability, delivery, and therapeutic outcomes. This may involve the use of organic or metallic nanoparticles as carriers for improved efficacy in targeted treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 128366-07-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,3,6 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 128366-07:
(8*1)+(7*2)+(6*8)+(5*3)+(4*6)+(3*6)+(2*0)+(1*7)=134
134 % 10 = 4
So 128366-07-4 is a valid CAS Registry Number.
128366-07-4Relevant articles and documents
MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH
-
Page/Page column 73-74, (2009/01/20)
The present invention provides screening methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors as well as modifiers capable of modulating chemosensory receptors and their ligands.
INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND METHODS FOR IDENTIFYING THE SAME
-
Page 134, (2010/02/08)
Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures (Ia), (Ib) including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein n, R1, R2, R3, R4, X, and Z are as defined herein. Compositions containing an inhibitor of MIF in combination with a pharmaceutically acceptable carrier are also provided, as well as methods for use of the same.